Inside Reproductive Health News Digest
Clinics navigate stagnant expansion while grappling with barriers to care and rising operational strain
The Palm Springs clinic suffered physical damage but no loss of embryos. The May 17 attack was condemned by the ASRM.
75% of patients screen clinics online, and 84% won’t consider providers with less than 4 stars
Patient churn rates exceeding 50% threaten clinical outcomes, operational efficiency, and long-term revenue growth
FET programs still favor HRT despite safety concerns — but AI-backed hormone tracking may remove key barriers
The Palm Springs clinic suffered physical damage but no loss of embryos. The May 17 attack was condemned by the ASRM.
Fertility clinics face growing liability and audit strain as outdated tracking systems clash with surging storage volume
The deal would add 14 IVF clinics in India and the UAE to IVI RMA’s portfolio, but has yet to be independently verified
Financial Counselors Underleveraged, Underutilized and Underappreciated in IVF Conversions
Oregon Medical Association supports anti-private equity law, ASRM, SART, don’t take position
Intended parents and donor-conceived children increasingly want flexible relationship options—but many clinics can't meet the need
As demand for IVF accelerates, the sector’s lack of lab innovation may be a liability with increased managed care
Lack of lifecycle engagement causes referral loss, low retention, and stalled revenue across patient touchpoints
High call volumes, outdated communication methods, strain staff, frustrated fertility patients
He will start on July 7 and will take the reins of a company that has experienced recent flux.
Clinics are seeing patients stall or drop out due to financing gaps. A new outcomes-based model aims to keep care within reach
For black-belt fertility specialist, Dr. Allison Bloom, every path to parenthood is honored.
U.S. IVF cycle volumes jumped 33% from 2020 to 2022, but gains slowed dramatically after initial COVID-era spike
Inception’s Legal Chief Weights in on Emerging Legislation on Embryo Rights, IVF Restrictions, PGT, and Excessive Reporting
One major supplier has 6-12 month inventory of U.S.-manufactured supplies. Supplies said not to be major expense for at least one major IVF practice.
Drains resources because of administrative burden, OB self-reporting, limited EMR capabilities, and 6% human error rate
Cumbersome injection protocols heighten risk of user error, exposing a critical weak point in modern fertility care
- CEO and C Suite 1
- Compliance 21
- IVF Lab 2
- International Care 2
- Mergers & Acquisitions 17
- Partnership & Recruitment 10
- Patient Relations 13
- Physician Leadership 1
- Practice Management 27
- Practice Ownership 1
- Private Equity 6
- Strategy 6
- Technological Innovation 19
- Technology 3
- Training & Education 2
- Venture Capital 5